Open Readings 2020 • P4-60
CHARACTERIZATION OF TOXIN-ANTITOXIN SYSTEM IN THE VICINITY OF CRISPR-CAS OPERON
Inga Songailienė1, Jonas Juozapaitis1, Giedrė Tamulaitienė1, Giedrius Sasnauskas1, Audronė Rukšėnaitė2, Virginijus Šikšnys1
1 Department of Protein - DNA Interactions, Institute of Biotechnology, Life Sciences Center, Vilnius University, Lithuania
2 Department of Biological DNA Modification, Institute of Biotechnology, Life Sciences Center, Vilnius University, Lithuania
Bacteriophages (viruses of bacteria) represent a lethal threat to bacteria. In the course of evolution, microbes developed many tools to fight viral infections. CRISPR-Cas system in prokaryotes functions as an adaptive immune system that provides acquired resistance against invasive genetic elements like viruses or plasmids. CRISPR-Cas systems are very diverse and differ by gene arrangement and composition of the effector complex [1]. During recent years molecular mechanisms of CRISPR-Cas were established [2–6].
Auxiliary genes are found quite often in the vicinity of CRISPR-Cas systems; however, their role in the CRISPR-provided bacterial immunity remains unclear [1, 7].
The study aims to characterize a toxin-antitoxin (TA) module, located in the same operon with a Type I CRISPR-Cas system in cyanobacteria. The link between CRISPR-Cas and particular TA system is unknown, while biochemical and structural data on the TA system is also lacking.
Genes of interest were cloned in heterologous host E. coli. In vivo assays showed that the two-gene module forms an active toxin-antitoxin system. Protein expression conditions were optimized and proteins were purified from E. coli. Amino acids, critical for the function of the TA system, were determined both in vivo and in vitro. Finally, protein crystals, suitable for X-ray crystallography, were obtained. Collected data was sufficient to determine the ternary structures of the toxin and toxin-antitoxin complex.
[1] K. S. Makarova et al., Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants, Nat. Rev. Microbiol. 18, (2020).
[2] G. Gasiunas, R. Barrangou, P. Horvath, and V. Siksnys, Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria, Proc. Natl. Acad. Sci. 109, E2579–E2586 (2012).
[3] T. Sinkunas et al., In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus, EMBO J. 32, 385–394 (2013).
[4] O. O. Abudayyeh et al., C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector, Science 353, aaf5573 (2016).
[5] M. Kazlauskiene, G. Tamulaitis, G. Kostiuk, Č. Venclovas, and V. Siksnys, Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition, Mol. Cell 62, 295–306 (2016).
[6] W. X. Yan et al., Functionally diverse type V CRISPR-Cas systems, Science 363, 88-91 (2019).
[7] S. A. Shmakov, K. S. Makarova, Y. I. Wolf, K. V. Severinov, and E. V. Koonin, Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis, Proc. Natl. Acad. Sci. 115, E5307–E5316 (2018).